trending Market Intelligence /marketintelligence/en/news-insights/trending/_brojezzflwkangslvwldq2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Novelion seeking approval for leptin drug in EU

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Novelion seeking approval for leptin drug in EU

Novelion Therapeutics Inc. is seeking approval for Metreleptin in Europe.

The company filed an application with the European Medicines Agency to market Metreleptin as therapy for leptin deficiency in patients with lipodystrophy, the loss of fat from a part of the body.

Metreleptin was orphan-drug designated in the EU in July 2012.